These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15142325)

  • 1. Fluctuations in vancomycin CNS tissue concentrations following intermittent and continuous infusions in the rat.
    Luer MS; Neill KK; Gurley BJ; Shannon ML; Killian AD; Rodvold KA
    Neurol Res; 2004 Apr; 26(3):312-5. PubMed ID: 15142325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
    Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
    Jeurissen A; Sluyts I; Rutsaert R
    Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices.
    Jorgenson L; Reiter PD; Freeman JE; Winston KR; Fish D; McBride LA; Handler MH
    Pediatr Neurosurg; 2007; 43(6):449-55. PubMed ID: 17992031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
    Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
    J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
    Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
    Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal vancomycin continuous infusion: still a confusion?
    Gwee A; Cranswick N; Metz D; Coghlan B; Daley AJ; Bryant PA; Curtis N
    Pediatr Infect Dis J; 2014 Jun; 33(6):600-5. PubMed ID: 24378952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure Variability and Target Attainment of Vancomycin: A Systematic Review Comparing Intermittent and Continuous Infusion.
    van Maarseveen EM; Gipmans SGH; van Zanten ARH
    Ther Drug Monit; 2020 Jun; 42(3):381-391. PubMed ID: 32432845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion.
    Vuagnat A; Stern R; Lotthe A; Schuhmacher H; Duong M; Hoffmeyer P; Bernard L
    J Clin Pharm Ther; 2004 Aug; 29(4):351-7. PubMed ID: 15271102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin cerebrospinal fluid concentrations after intravenous administration in premature infants.
    Reiter PD; Doron MW
    J Perinatol; 1996; 16(5):331-5. PubMed ID: 8915929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.
    De Waele JJ; Danneels I; Depuydt P; Decruyenaere J; Bourgeois M; Hoste E
    Int J Antimicrob Agents; 2013 May; 41(5):434-8. PubMed ID: 23410793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone penetrance of locally administered vancomycin powder in a rat femur fracture model.
    Working ZM; Frederiksen H; Drew A; Loc-Carrillo C; Kubiak EN
    Injury; 2017 Jul; 48(7):1459-1465. PubMed ID: 28456368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion.
    Byl B; Jacobs F; Wallemacq P; Rossi C; de Francquen P; Cappello M; Leal T; Thys JP
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2015-7. PubMed ID: 12760889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of vancomycin into human lung tissue.
    Cruciani M; Gatti G; Lazzarini L; Furlan G; Broccali G; Malena M; Franchini C; Concia E
    J Antimicrob Chemother; 1996 Nov; 38(5):865-9. PubMed ID: 8961057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Level of evidence for therapeutic drug monitoring of vancomycin].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of vancomycin administered as prophylaxis before cardiac surgery.
    Kitzes-Cohen R; Farin D; Piva G; Ivry S; Sharony R; Amar R; Uretzky G
    Ther Drug Monit; 2000 Dec; 22(6):661-7. PubMed ID: 11128233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
    Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
    Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections.
    Berthoin K; Ampe E; Tulkens PM; Carryn S
    Int J Antimicrob Agents; 2009 Dec; 34(6):555-60. PubMed ID: 19782538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.